InflammaSense is pumped to participate in the Unlimited Networking Lounge on January 30th! ?? We're eager to connect with visionary VCs and share our groundbreaking hybrid digital health and medical device technology. Our mission: revolutionize mental health care by objectively quantifying and stratifying severity, enabling better recruitment of reliable responder patients and significantly reducing clinical trial costs. ?? Let’s innovate together—see you there! ?? Join for free 1,000s of investors & startups on Zoom at the Early-Stage Virtual Conf on Jan 30. I've signed up with our startup – InflammaSense revolutionizes mental health clinical trials with a hybrid platform combining EMR data and novel autonomic neurography (ANG) biomarkers; this technology reduces non-responder rates, cuts trial costs for Depression & PTSD. Read these VC stories at the bottom of the PDF, starting on page 2, to explore the core motivations of investors based on experience attracting hundreds of Family Offices, Funds of Funds, VC & PE funds, Angel syndicates to virtual events. And then: 1. Register for the event for free:?https://inniches.com/es 2. Like and comment to receive the list with 128 investor contacts & 100 TechCrunch pitch deck teardowns.?@Max Pog’s team will send it to you via DM or a connection request. 3. Max will gift 100+ books & cakes to participants of the event. Repost to increase your chances.
InflammaSense
医疗设备制造业
San Diego,California 135 位关注者
InflammaSense: A Mental Health Clinical Trials Solution
关于我们
One liner: Wouldn't it be amazing to recruit reliable responder patients for your clinical trial, dramatically reducing costs and minimizing the risk of trial failure? The InflammaSense mental health solution stands out for its ability to predict mental health severity at a granularity not possible until now. The blended mental health stratification approach including: electronic record (EMR) algorithmic modeling and novel Autonomic Neural and Point of Care Molecular Biomarker scans (5 min), radically reduces non-responder rates (up to 80%) and mental health disorder clinical trial costs ($5Mil-$2Bill/trial). Proof of Concept: InflammaSense has built and deployed proof of concept EMR model (Trained 13.4 Mill) and wearable patch system for fast mental health severity prediction in less than < 5 min. The system has been tested in 50 subjects and has shown promising results (sensitivity and specificity >90%) Seamlessly Integrated into Current Vital Sign Monitoring Comfortable for Patients 24/7 Continuous Monitoring and Support for Your Team PRECISE ENGINEERING Immediately transmit inflammation based diseases severity for clinical trials. InflammaSense exists at the cutting edge of technology. Our novel and purpose-made machine-learning algorithms drive high quality and reproducible data analyses and the generation mental health severity stratification and inflammation associated with disease. A clinical decision support tool you can trust Backed by peer-reviewed research and clinical trials FULL INTEGRATION FHR-Enabled Epic App Orchard and Cerner App Friendly All Workflows Can Be Completed From Within Your EHR
- 网站
-
www.inflammasense.com
InflammaSense的外部链接
- 所属行业
- 医疗设备制造业
- 规模
- 2-10 人
- 总部
- San Diego,California
- 类型
- 私人持股
- 创立
- 2023
地点
-
主要
3195 Voigt Dr
US,California,San Diego,92093
InflammaSense员工
-
Rahul Singh
at InflammaSense, Inc
-
Yifeng Bu
Ph.D. in Electrical and Computer Engineering @ UCSD; Director of Design Engineering @ Inflammasense; Founding Engineer @ Healthcare startup;
-
Imanuel Lerman
Neurotechnology | Neuroimmune Sensing | Artificial Intelligence for Health and Wellness | InflammaSense | UCSD/VA Health Clinical Neuromodulation…
动态
-
Thrilled to announce the publication of our new paper,?Next Generation Bioelectronic Medicine: Making the Case for Non-Invasive Closed-Loop Autonomic Neuromodulation, now live in?Bioelectronic Medicine! This work explores the transformative potential of non-invasive, closed-loop systems in autonomic neuromodulation, paving the way for personalized healthcare solutions. A huge shoutout to the incredible co-authors (Yifeng Bu,?Rahul Singh, Harold Silverman, PhD, Anuj Bhardwaj,?Alexander Mann, Alik Widge,?Joseph Palin, Chris Puleo & Hubert Lim and to the many many neurotechnology pioneers for their dedication and brilliance in this fast moving field. Grateful for the support and collaboration from Convergent Research, Defense Advanced Research Projects Agency (DARPA), and Biomedical Advanced Research and Development Authority (BARDA)—partners who share the vision of advancing bioelectronic medicine into new frontiers. Also thank you to our valuable collaborators Aidan Canning, Tuan Vo-Dinh, Ruy Ribeiro, Sopyda Y., and Mihika Shilpi! Let’s continue pushing the boundaries of what's possible in healthcare! Check out the full paper here: https://lnkd.in/gTUnWzwM
Great start of the year for Bioelectronic Medicine: https://lnkd.in/darDvT2 Just published: Next generation bioelectronic medicine: making the case for non-invasive closed-loop autonomic neuromodulation Imanuel Lerman,?Yifeng Bu,?Rahul Singh,?Harold Silverman, PhD,?Anuj Bhardwaj,?Alex J. Mann,?Alik Widge,?Joseph Palin,?Chris Puleo?&?Hubert Lim? https://lnkd.in/e8K5B44k ? Submit your best science to Bioelectronic Medicine!
-
-
? With 06 days until TechCon SoCal! ? Meet the trailblazers set to transform industries at our Startup Innovation Showcase Finalists presentation! This event will spotlight some of the most exciting new ventures in the tech space. Congratulations to our top contenders: Dimitri Schreiber, Founder, AIR Surgical, Inc. Sinan G?lhan, Co-founder & CEO, GolTech Lior Root, Co-founder & CEO, Loopholes Jiajer Ho, CEO/Co-founder, DeepWater Exploration Inc. Imanuel Lerman, CEO, InflammaSense Farzad Rahbar, Co-founder & CEO, FlyX Technologies Adam Blair, Co-founder & CEO, Site Bionics Jeremy Malecha, CEO & Co-founder, Biocanic These innovators are redefining what's possible in their fields, from medical technology to sustainable engineering. For an in-depth look at each finalist and what makes their ventures stand out, check out the full press release: https://lnkd.in/dtxB3VZR Join us to experience the future of innovation and see who will take home the top prize at this year’s showcase. Your support could mean everything to these emerging stars of technology and innovation. We look forward to seeing you there! ?? January 17-18, 2025 ?? San Diego, California ?? www.techconsocal.com Watch our teaser video to see what’s in store at TechCon SoCal 2025! https://lnkd.in/diacNCYS Tariq Ahmed Serhat Pala?Neal Bloom??Sufyan Subzwari NuFund Venture Group?Interlock Capital OPEN Silicon Valley?Orange County OC Startup Council OPEN Global Eric Weiss Ashok Kamal JJ Richa Misti Cain Ryan Kuder #TechConSoCal2025 #TechConSoCal #IndustryExperts #TechConference #InnovationSummit #TechTalks #Innovation #Technology #Networking #ArtificialIntelligence #DigitalHealth #Robotics #startups #vc #SandDiegoStartup #Founders #ConsumerTech
-
-
Also checkout Imaneul’s work. He has been doing some great R&D in this space. Imanuel Lerman Pejman (PJ) Naraghi
Clinical Overview of the Vagus Nerve (Cranial Nerve X) Anatomy & Function ? Type: Mixed nerve (sensory, motor, and parasympathetic). ? Origin: Arises from the medulla oblongata. ? Pathway: Exits the skull via the jugular foramen, travels through the neck, and innervates structures in the thorax and abdomen. ? Major Functions: ? Sensory: External ear, pharynx, larynx, and thoracoabdominal organs. ? Motor: Muscles of the pharynx, larynx, and soft palate (except stylopharyngeus and tensor veli palatini). ? Parasympathetic: Regulates heart rate, digestion, and respiratory function. Clinical Examination 1. Palate Elevation: ? Ask the patient to say “Ah.” Asymmetry in palate elevation suggests vagus nerve dysfunction. 2. Gag Reflex: ? Stimulus applied to the posterior pharyngeal wall; tests afferent glossopharyngeal and efferent vagus nerves. 3. Voice and Swallowing: ? Check for hoarseness (recurrent laryngeal nerve involvement) and dysphagia. Common Clinical Manifestations 1. Dysfunction of the Vagus Nerve: ? Hoarseness: Due to recurrent laryngeal nerve damage. ? Dysphagia: Impaired swallowing from motor dysfunction. ? Loss of Gag Reflex: Indicates afferent or efferent pathway disruption. 2. Vasovagal Syncope: ? Overactivation leads to bradycardia and hypotension, causing fainting. 3. Gastroparesis: ? Delayed gastric emptying due to vagus nerve impairment. Causes of Vagus Nerve Injury 1. Trauma or Surgery: ? Thyroidectomy or carotid endarterectomy may damage branches like the recurrent laryngeal nerve. 2. Compression: ? Tumors, aneurysms, or base of skull lesions. 3. Neuropathies: ? Diabetes, viral infections, or autoimmune diseases. Therapeutic Relevance 1. Vagus Nerve Stimulation (VNS): ? Used for epilepsy and refractory depression. 2. Management of Gastroparesis: ? Treatment often includes dietary modifications, medications, and in some cases, electrical stimulation. #VagusNerve #Health #Medicine #Doctor #Nurse #MBBS
-
Awesome to see this in Scientific American! "When the vagus nerve brings news of dangerous inflammation in the body, the brain sends down signals to soothe it." At InflammaSense we have built the technology to continuously listen to the autonomic "vagus news" nervous system to better predict patients that are responders to your pharmaceutical and or neuromodulation therapy. Our patent pending tools are integrated into the electronic medical record to radically reduce clinical trial costs through cost saving trial enrichment.
-
InflammaSense is looking forward to debuting at JPM this year! Our CEO Imanuel Lerman is excited to meet strategic partners and investors at the Bullpen. If you like to jump to the front of meeting line email him at [email protected] or message him on LinkedIn!
Meet Imanuel Lerman, InflammaSense Chief Executive Officer, at Pitch Fest San Francisco, January 13 & 14. Learn more about InflammaSense: https://inflammasense.com/ #InflammaSense harnesses the power of Autonomic Neurography or "ANG" to predict disease severity early and accurately.?ANG recordings predict likelihood of individual disease response to therapeutics, radically enhancing accurate treatment selection. By transforming complex biological signals into actionable insights, we’re empowering:?(1) clinical researchers to enrich clinical trials, and (2) healthcare providers to make timely, life-saving decisions. Two Iconic Venues: Venue 1 | Golden Gate Yacht Club Mon, Jan 13 | 2 - 5 pm Request an Invitation: https://lnkd.in/gBeEn-jw Venue 2 | Hilton San Francisco Union Square Tue, Jan 14 | 2 - 5 pm Open Registration: https://lnkd.in/gyMxg2C7 #PitchFest SF Lineup: 2 - 3 pm | #Therapeutics Plakous Therapeutics Sarcomatrix Persista Bio Inc. Magnetic Tides 3 - 4 pm | #MedTech ARC Medical Inc. GoNo Food Finder InflammaSense iRxReminder LLC Zepto Life Technology SafetySpect, Inc 4 - 5 pm | #ArtificialIntelligence CEREBRIU Genialis #QAiBio Ankr Health Coaching Staff: Head Coach: Michael Hill Chief of Staff: Brandon Bogdalek Key Opinion Leaders: KATRINA ROGERS Investor Relations: Karim ReFaey, M.D., M.S.E. Regulatory: Ernesto Chanona Military Medicine: Jill Sorensen Banking: Ben Kromnick Deck Strategy: Amelia Newbury Collaborations: James Zanewicz, JD, LLM, RTTP Public Relations: Dave Whelan Market Research: Danny Smith Thank You Sponsors: Bullpen CSSi LifeSciences MTEC | Medical Technology Enterprise Consortium Mercury About Bullpen’s Pitch Fest San Francisco: https://lnkd.in/gZ5Mqqk6 The purpose of Pitch Fest is to gather international life science Bullpen Members, Guests and resources at regional life science hubs to support each other as a community of Dealmakers. There is no single winner at Pitch Fest – we all win. #Bullpen at #JPM2025: https://lnkd.in/gcXNSkBA Enjoy a world-class venue with shoreline views of the Golden Gate Bridge and Alcatraz at Bullpen HQ. Bullpen is an invite-only Club gathering Life Science Investors and CxOs with a shared goal of helping each other. We prepare for and attend premier industry events together. Our #Mantra: Find Someone to Help. Repeat. Mission: https://lnkd.in/gemP3WGC Membership Inquiries: https://lnkd.in/gfnyBEpK Member Roster: https://lnkd.in/gqJA_nKB Full Schedule: https://lnkd.in/giP5dNkR
-
-
InflammaSense placed 2nd at PitchForce, adding to the InflammaSense outreach portfolio!
Neurotechnology | Neuroimmune Sensing | Artificial Intelligence for Health and Wellness | InflammaSense | UCSD/VA Health Clinical Neuromodulation Pain & Mental Health | VA Center for Stress and Mental Health
Thanks to PitchForce for having InflammaSense this week. We are thrilled to have placed 2nd amongst all companies pitching. More importantly, we are grateful to have the valuable follow-on meetings with investors.
-
-
Neurotechnology | Neuroimmune Sensing | Artificial Intelligence for Health and Wellness | InflammaSense | UCSD/VA Health Clinical Neuromodulation Pain & Mental Health | VA Center for Stress and Mental Health
So proud of Dr. Yifeng Bu (Dr. Troy Bu); he successfully defended his thesis, has graduated and now is joining InflammaSense as employee #1.
-